BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 6526330)

  • 1. [Usefulness of an enzymatic method of determining placental lactogen and estriol in the serum and cardiotocographic recording in monitoring high-risk pregnancy].
    Pisarek-Miedzińska D; Taszycka E; Merkel M; Wierzbicki A; Wardyńska-Szlasa A
    Ginekol Pol; 1984 Aug; 55(8):583-94. PubMed ID: 6526330
    [No Abstract]   [Full Text] [Related]  

  • 2. [Management of pregnancy at risk: evaluation of fetal movements, determination of total plasma estriol and placental lactogen hormone in relation to fetal heart rhythm].
    Mbanzulu PN; Leng JJ; Commenges D; Salamon R
    J Gynecol Obstet Biol Reprod (Paris); 1986; 15(6):779-84. PubMed ID: 3794214
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Placental perfusion, endocrine parameters of pregnancy and cardiotocographic non-stress tests in cases of intrauterine retardation].
    Doszpod J; Török M; Prievara F; Csákány MG; Gáti I
    Zentralbl Gynakol; 1984; 106(21):1413-8. PubMed ID: 6516633
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The hormonal assessment of fetal status: total estriol and chorionic somatomammotropin].
    Espinosa de los Monteros A; Patiño Lemus R; Avila Rosas H; Karchmer S
    Ginecol Obstet Mex; 1988 Oct; 56():268-72. PubMed ID: 3154253
    [No Abstract]   [Full Text] [Related]  

  • 5. [Biophysical and biochemical fetal monitoring].
    Richter R
    Gynakol Rundsch; 1984; 24 Suppl 1():102-7. PubMed ID: 6394440
    [No Abstract]   [Full Text] [Related]  

  • 6. Antepartal cardiotocography in the assessment of fetal outcome.
    Käär K
    Acta Obstet Gynecol Scand Suppl; 1980; 94():1-56. PubMed ID: 6935909
    [No Abstract]   [Full Text] [Related]  

  • 7. [Prognostic significance of the placental lactogen and estriol content of the blood pregnant women].
    Lopatchenko OI
    Akush Ginekol (Mosk); 1981 May; (5):32-4. PubMed ID: 7294303
    [No Abstract]   [Full Text] [Related]  

  • 8. [Correlation of HPL and free serum estriol during normal and disturbed pregnancy (author's transl)].
    Geibel W; Rindt W
    Z Geburtshilfe Perinatol; 1977 Oct; 181(5):321-4. PubMed ID: 415446
    [No Abstract]   [Full Text] [Related]  

  • 9. Oxytocin challenge test results compared with simultaneously studied serum human placental lactogen and free estriol levels in high-risk pregnant women.
    Spellacy WN; Cruz AC; Kalra PS; Kellner KR; Quinlan RW; Buhi WC; Birk SA
    Am J Obstet Gynecol; 1979 Dec; 135(7):917-23. PubMed ID: 507132
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The monitoring of risk pregnancies by E3 and HPL].
    Bieglmayer C; Spona J
    Acta Univ Palacki Olomuc Fac Med; 1981; 101():38-42. PubMed ID: 6211052
    [No Abstract]   [Full Text] [Related]  

  • 11. [Monitoring of at-risk pregnancies through E3 and HPL].
    Bieglmayer C; Spona J
    Acta Univ Palacki Olomuc Fac Med; 1981; 101():38-42. PubMed ID: 6242692
    [No Abstract]   [Full Text] [Related]  

  • 12. [Radioimmunologic determination of estriol, HPL, and alpha fetoprotein in maternal serum and their values in pregnancies at risk (proceedings)].
    Arnold P; Rauskolb R; Jovanović V; Bleyl H
    Arch Gynakol; 1977 Jul; 224(1-4):123-4. PubMed ID: 74991
    [No Abstract]   [Full Text] [Related]  

  • 13. [Significance of the determination of free estriol (E3) and of placental lactogen (HPL) in the monitoring of high-risk pregnancy].
    Ghionni A; Briani G; Pasini L
    Minerva Ginecol; 1979; 31(1-2):13-8. PubMed ID: 471308
    [No Abstract]   [Full Text] [Related]  

  • 14. Human placental lactogen and plasma total oestriol values in the third trimester of pregnancy.
    Freedman RS; Van der Walt LA
    S Afr Med J; 1975 Oct; 49(43):1777-80. PubMed ID: 1242544
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Comparison of plasmaestriol and HPL in high risk pregnancies].
    Duenhoelter JH; Whalley PJ
    Arch Gynecol; 1979 Jul; 228(1-4):229-30. PubMed ID: 485318
    [No Abstract]   [Full Text] [Related]  

  • 16. Human placental lactogen and unconjugated estriol concentrations in twin pregnancy: monitoring of fetal development in intrauterine growth retardation and single intrauterine fetal death.
    Trapp M; Kato K; Bohnet HG; Gerhard I; Weise HC; Leidenberger F
    Am J Obstet Gynecol; 1986 Nov; 155(5):1027-31. PubMed ID: 3777044
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Placental alkaline phosphatase compared with human placental lactogen and oestriol in high-risk pregnancies.
    Ronin-Walknowska E; Holmgren PA; von Schoultz B; Stigbrand T
    Gynecol Obstet Invest; 1984; 18(4):206-11. PubMed ID: 6510780
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Correlation of estriol and HPL with the course of pregnancy (proceedings)].
    Geibel W; Rindt W
    Arch Gynakol; 1977 Jul; 224(1-4):119-20. PubMed ID: 579740
    [No Abstract]   [Full Text] [Related]  

  • 19. [Radioimmunological studies for the diagnosis of the status of the fetus].
    Kulakov VI; Laricheva IP; Didina NM
    Med Radiol (Mosk); 1980 Sep; 25(9):62-5. PubMed ID: 6158643
    [No Abstract]   [Full Text] [Related]  

  • 20. Maternal serum levels of estriol, prolactin, human placental lactogen and chorionic gonadotrophin related to fetal sex in normal and abnormal pregnancies.
    Lagerström M; Bremme K; Eneroth P
    Gynecol Obstet Invest; 1990; 30(4):198-203. PubMed ID: 2289699
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.